Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma

A 63-year-old man with castrate-resistant metastatic prostate adenocarcinoma with known osseous and pelvic nodal involvement presented with progressive dyspnea for one week. Complete cardiopulmonary evaluation revealed a restrictive lung defect that could not be attributed to any of his previous the...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrew Meyer, Rachel Angelica Mariani, Chadi Nabhan
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Case Reports in Medicine
Online Access:http://dx.doi.org/10.1155/2012/980920
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695590392266752
author Andrew Meyer
Rachel Angelica Mariani
Chadi Nabhan
author_facet Andrew Meyer
Rachel Angelica Mariani
Chadi Nabhan
author_sort Andrew Meyer
collection DOAJ
description A 63-year-old man with castrate-resistant metastatic prostate adenocarcinoma with known osseous and pelvic nodal involvement presented with progressive dyspnea for one week. Complete cardiopulmonary evaluation revealed a restrictive lung defect that could not be attributed to any of his previous therapies. On presentation, physical examination revealed coarse breath sounds diffusely with hypoxemia. Computed tomography of the chest showed severe bilateral airspace opacities and ground-glass appearance most consistent with interstitial pneumonitis. The patient was intubated due to progressive hypoxemia and worsening respiratory status despite empiric antibiotics and high dose steroids. Subsequent emergent bronchoscopy with transbronchial biopsies revealed atypical intralymphatic cells that stained positively for prostate-specific antigen and prostatic-specific acid phosphatase, confirming the diagnosis of intralymphatic pulmonary metastasis from prostate adenocarcinoma. Lymphangitic pulmonary metastasis from prostate adenocarcinoma is exceedingly rare, with few reported cases that are biopsy-proven. Herein, we describe a rare case of biopsy-proven lymphangitic pulmonary metastasis in the setting of castrate-resistant prostate adenocarcinoma and provide a comprehensive literature review.
format Article
id doaj-art-d057199ca7b14287b605723c86e43914
institution DOAJ
issn 1687-9627
1687-9635
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Case Reports in Medicine
spelling doaj-art-d057199ca7b14287b605723c86e439142025-08-20T03:19:43ZengWileyCase Reports in Medicine1687-96271687-96352012-01-01201210.1155/2012/980920980920Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate AdenocarcinomaAndrew Meyer0Rachel Angelica Mariani1Chadi Nabhan2Department of Medicine, Advocate Lutheran General Hospital, Park Ridge, Chicago, IL 60068, USADepartment of Pathology, University of Illinois at Chicago, Chicago, IL 60612, USADepartment of Medicine, Division of Hematology and Oncology, Advocate Lutheran General Hospital, Park Ridge, Chicago, IL 60068, USAA 63-year-old man with castrate-resistant metastatic prostate adenocarcinoma with known osseous and pelvic nodal involvement presented with progressive dyspnea for one week. Complete cardiopulmonary evaluation revealed a restrictive lung defect that could not be attributed to any of his previous therapies. On presentation, physical examination revealed coarse breath sounds diffusely with hypoxemia. Computed tomography of the chest showed severe bilateral airspace opacities and ground-glass appearance most consistent with interstitial pneumonitis. The patient was intubated due to progressive hypoxemia and worsening respiratory status despite empiric antibiotics and high dose steroids. Subsequent emergent bronchoscopy with transbronchial biopsies revealed atypical intralymphatic cells that stained positively for prostate-specific antigen and prostatic-specific acid phosphatase, confirming the diagnosis of intralymphatic pulmonary metastasis from prostate adenocarcinoma. Lymphangitic pulmonary metastasis from prostate adenocarcinoma is exceedingly rare, with few reported cases that are biopsy-proven. Herein, we describe a rare case of biopsy-proven lymphangitic pulmonary metastasis in the setting of castrate-resistant prostate adenocarcinoma and provide a comprehensive literature review.http://dx.doi.org/10.1155/2012/980920
spellingShingle Andrew Meyer
Rachel Angelica Mariani
Chadi Nabhan
Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
Case Reports in Medicine
title Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
title_full Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
title_fullStr Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
title_full_unstemmed Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
title_short Lymphangitic Pulmonary Metastases in Castrate-Resistant Prostate Adenocarcinoma
title_sort lymphangitic pulmonary metastases in castrate resistant prostate adenocarcinoma
url http://dx.doi.org/10.1155/2012/980920
work_keys_str_mv AT andrewmeyer lymphangiticpulmonarymetastasesincastrateresistantprostateadenocarcinoma
AT rachelangelicamariani lymphangiticpulmonarymetastasesincastrateresistantprostateadenocarcinoma
AT chadinabhan lymphangiticpulmonarymetastasesincastrateresistantprostateadenocarcinoma